Retatrutide, an experimental drug by Eli Lilly, shows promising results in weight loss by targeting three hormones, ...

More than 90 per cent of weight loss jab users are forced to pay for treatment privately due to their slow roll-out on the NHS ...

The proportion of obese Indians has risen from 25 per cent in 2013 to 40 per cent in 2023, highlighting the need for ...

Donald Trump and his advisers are about to launch a consequential battle against unhealthy food producers and the ...

Ozempic, inflation and the Trump presidency will likely dictate food waste trends in the US in 2025, according to non-profit ...

"We grew up watching the media scrutinize women's bodies relentlessly," Becky Jones, a millennial woman, told Newsweek.

Nicole Albanese, PharmD, discusses the science behind weight-loss drugs, their potential to treat other addictions as well as ...

While talk show queen Oprah Winfrey has declined to name the brand she uses, she’s among the Hollywood stars who have been ...

Eli Lilly's experimental weight loss drug, retatrutide, has demonstrated encouraging results in helping obese adults lose weight.

Some people may turn to private healthcare providers in order to get their hands on the weight loss jabs. However, Britons ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Indeed, Ozempic and Wegovy may well be in the news in the coming months—if Trump imposes the massive tariffs on Denmark that ...